Citas bibligráficas
Reyna, B., (2024). Amplitud de distribución eritrocitaria elevada como predictor de mortalidad de pacientes con enfermedad renal crónica en estadio III y IV [Tesis, Universidad Privada Antenor Orrego]. https://hdl.handle.net/20.500.12759/35111
Reyna, B., Amplitud de distribución eritrocitaria elevada como predictor de mortalidad de pacientes con enfermedad renal crónica en estadio III y IV [Tesis]. PE: Universidad Privada Antenor Orrego; 2024. https://hdl.handle.net/20.500.12759/35111
@misc{renati/380541,
title = "Amplitud de distribución eritrocitaria elevada como predictor de mortalidad de pacientes con enfermedad renal crónica en estadio III y IV",
author = "Reyna Jiménez, Brenda Karen",
publisher = "Universidad Privada Antenor Orrego",
year = "2024"
}
Demonstrate if high red blood cell distribution width is a predictor of mortality in patients with chronic kidney disease (CKD). Methodology: A retrospective cohort was analyzed in 264 patients with stage III-IV CKD treated at the Víctor Lazarte Echegaray Hospital in the years 2019 to 2022. The exposure variable was high RDW (RDW > 14.9%) and the outcome variable was all-cause mortality. Additionally, other covariates were related to mortality. In the statistical analysis, the X2- test was used for the bivariate analysis and the Poisson regression for the multivariate evaluation. In both cases, the association was considered significant if p < 0.05. Results: In total there were 64 (24.2%) deceased patients and 200 (75.8%) surviving patients. In the bivariate analysis, the variables related to a higher risk of all-cause mortality were high RDW (RR: 2.38; 95% CI: 1.58-3.60; p<0.001), age ≥ 75 years (RR: 1.77; IC 95%: 1.14-2.76; p=0.010), hypoalbuminemia (RR: 2.86; IC 95%: 1.80-4.53; p<0.001) and anemia (RR: 2.92; IC 95%: 1.90-4.49; p<0.001). In the multivariate analysis, the variables related to mortality were hypoalbuminemia (RR: 2.129; IC 95%: 1.157- 3.916; p=0.015) and anemia (RR: 2.368; IC 95%: 1.272-4.409; p=0.007). Conclusion: High RDW was not predictor of all-cause mortality in patients with stage III- IV CKD.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons